BIBR 1048 in the Prevention of Venous Thromboembolism in Patients Undergoing Primary Elective Total Hip Replacement Surgery

Summary

* To determine the therapeutic window of BIBR 1048 in order to select doses for further studies in the development plan. * Twice daily regimen will be tested for most dose levels and once daily administration will also be evaluated when appropriate.

Timeline

Start

2000-10

Primary completion

2001-06

Completion

—

Drugs

Indications